“I want the brown spots lasered off” sounds wonderfully efficient. Pigment is rarely that cooperative.
Solar lentigines, post-inflammatory hyperpigmentation and melasma can all look brown on the face and require different treatment logic. A laser or IPL platform can target pigment without explaining why that pigment is there. That missing diagnosis is where expensive mistakes begin.
Where the choice actually differs
Three kinds of brown, three different plans| On | Sun spots | Post-inflammatory hyperpigmentation | Melasma |
|---|---|---|---|
| Why the pigment is there | Cumulative ultraviolet exposure | The aftermath of inflammation or injury — acne, eczema, burns, picking, procedures | A chronic acquired condition influenced by light exposure and hormones |
| What has to happen first | A clinician confirms the lesion is benign and appropriate for cosmetic treatment | Establish whether the inflammation is still active | Sun protection and trigger management, which no machine replaces |
| What treatment can do | Selected pigment lasers or IPL can be effective | Can improve pigment in one context and provoke more of it in another | Used in selected cases, usually as part of combination therapy |
| The risk that matters | Treating a new or changing lesion as a decorative inconvenience | More pigment, and more consequence in darker skin | Recurrence over years, and any language that promises erasure |
| Where the evidence lands | Effective for genuine lentigines, with device choice following skin tone | Depends on skin tone, the original trigger and how aggressive the treatment is | Inconsistent. A 2026 review found low-fluence Q-switched 1064-nm Nd:YAG improved on subgroup analysis while picosecond and fractional subgroups did not outperform controls |
What changes the answer: A platform can target pigment without ever explaining why that pigment is there. Pico is a pulse duration, not a diagnosis.
Sun spots are the easiest version of this, and still not automatic
Solar lentigines, commonly called age spots or sun spots, are localized areas of increased pigment associated with cumulative ultraviolet exposure. When a qualified clinician has confirmed that a lesion is benign and appropriate for cosmetic treatment, selected pigment lasers or IPL can be effective options.
The key phrase is confirmed that the lesion is appropriate for cosmetic treatment. A new, changing, irregular or otherwise concerning pigmented lesion should not be treated as a decorative inconvenience before it has been properly evaluated.
For genuine lentigines, treatment may involve IPL, Q-switched or picosecond systems, or other wavelength-specific approaches depending on skin tone and device availability. The best choice is not automatically the newest pico platform.
With PIH, the pigment is the receipt for something else
PIH appears after inflammation or injury — acne, eczema, burns, picking, procedures. The dark mark is a record of something that has already irritated the skin, which is precisely why the next thing done to that skin is not a neutral act.
Another inflammatory procedure can improve pigment in one context and provoke more of it in another. Four things decide which: skin tone, the original trigger, whether the inflammation is still active, and how aggressive the treatment is. The third one decides the booking. Treating a mark while the process that made it is still running is how people end up with two.
In darker skin, PIH risk becomes particularly important because greater epidermal melanin can increase the consequences of thermal or light-based injury. A provider should be able to explain why a device is worth that trade rather than treating every brown mark as a laser target.
Why “pigment removal” language gets dangerous around melasma
Melasma is a chronic acquired pigmentary condition influenced by factors including light exposure and hormones. It is common in medium and darker skin tones and can persist or recur for years.
Sun protection is foundational. The American Academy of Dermatology specifically notes that melasma treatment plans include sun protection, and visible light may also matter for some patients. A machine cannot replace the ongoing trigger-management part of the plan.
Laser and light treatments can be used in selected melasma cases, often as part of combination therapy, but the literature is inconsistent enough that “laser for melasma” should never sound like a straightforward pigment-erasing service.
A 2026 systematic review and meta-analysis found low-fluence Q-switched 1064-nm Nd:YAG showed statistically significant improvement in subgroup analysis, while picosecond and fractional laser subgroups did not significantly outperform controls in that analysis. Other systematic reviews have reported benefit with picosecond or combination approaches. Two bodies of evidence, two answers, and the gap between them is not noise: it is the wavelength, the fluence, whether anything was combined with it, and who was enrolled. So the honest version of “laser for melasma” arrives with four conditions attached, and nobody prints four conditions on a menu.
A trillionth of a second is a specification, not a target
Picosecond lasers deliver very short pulses and can be used for tattoo pigment and selected pigmentary concerns. “Pico facial” has also become marketing shorthand for a broad category of treatments.
The device may be technically sophisticated. The question remains ordinary: what pigment is being treated, what wavelength is being used, and what evidence supports that indication in your skin?
A picosecond laser that is excellent at one target does not become a universal complexion corrector because the pulse is measured in trillionths of a second.
IPL can be excellent for photodamage and still be wrong for your pigment
IPL and BBL can improve selected sun-related pigment and vascular changes. They also deliver broad-spectrum light that can interact with epidermal melanin.
For discrete sun damage in an appropriate skin type, that can be a useful match. For melasma or PIH-prone skin, the risk-benefit calculation can be different. Recent tanning makes it different again.
This is why the phrase “photofacial for pigmentation” needs a second sentence.
Resurfacing treats texture and pigment differently
Fractional CO₂, Er:YAG and nonablative fractional lasers may improve aspects of photodamage and dyschromia while primarily being used for resurfacing and remodeling. They should not be chosen because you want a brighter complexion. That is a wish, not an indication.
If texture, scars and pigment are all present, combination treatment may make sense. It may also compound recovery and pigment risk. Ask which problem each component is intended to solve.
What the three-way split leaves out
The tree above sorts most faces. It does not sort all of them, and three categories sit outside it:
- Freckles and ephelides: genetically influenced pigment that may simply return with sun exposure, which makes “removal” an odd word for it.
- Nevi and other lesions: these may require diagnostic assessment rather than cosmetic treatment at all, and that is a different appointment with a different person.
- Mixed pigment: more than one process can coexist on one face, and a plan built for the most visible one can make the quieter one worse.
If the clinic cannot tell you which category it believes it is treating, the laser discussion is premature.
Questions that matter more than “Which laser do you use?”
- What is the diagnosis or working diagnosis for this pigment?
- Do any lesions need evaluation before cosmetic treatment?
- Is this melasma, PIH, sun-related pigment or a mixture?
- What exact device, wavelength and settings family are you considering?
- How does my skin tone and history of dark marks change the risk?
- What is the chance of rebound pigmentation or PIH?
- What sun and visible-light protection is part of the plan?
- Will topical treatment or trigger control be necessary before or after the procedure?
- What would make you choose not to use a laser or IPL?
Pigment is a description, not a diagnosis
Sun spots can be satisfying laser targets. PIH requires respect for the inflammation that created it. Melasma is a chronic pigment disorder that can punish simplistic treatment plans. The device comes after that distinction, not before it.
The machine may remove pigment. Good judgment decides whether that pigment should be targeted in the first place.
Evidence check: Moderate
Evidence level: moderate for selected laser/light treatment of benign pigmentary concerns; mixed and modality-dependent for melasma. Recurrence and PIH risk materially affect real-world outcomes.
Sources reviewed August 8, 2026:
- American Academy of Dermatology: Melasma Overview.
- American Academy of Dermatology: Melasma Self-Care.
- 2026 systematic review and meta-analysis of laser-based therapies for melasma.
- Systematic review and meta-analysis of picosecond alexandrite laser in melasma.
- Systematic review and network meta-analysis of laser-related therapy for melasma.
This article is educational. New, changing or unexplained pigment should be appropriately evaluated rather than assumed to be benign cosmetic discoloration.
